WEALTH ENHANCEMENT ADVISORY SERVICES, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1632972
PLYMOUTH, MN
Position in REGN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$21,125,535
-$7,922,638 QoQ
Shares Held
33,880
-9.9% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#9
of 131 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 2.33477965701467.ToString("F0")%
Shared 0.ToString("F0")%
None 97.66522034298532.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Sep 30, 2024CallValue
$946,116
CallShares
900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $166,117,226 across 147 Biotechnology names. REGN ranks #2 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45,889 | $22,794,442 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
33,880 | $21,125,535 | |
| 3 | INCY |
Incyte Corp
|
151,505 | $17,174,606 | |
| 4 | EXEL |
Exelixis, Inc.
|
207,728 | $11,302,480 | |
| 5 | RPRX |
Royalty Pharma plc
|
179,888 | $10,086,320 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
76,278 | $6,632,372 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
70,797 | $5,541,281 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
19,919 | $4,875,573 |
All Filings in REGN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,125,535 | 33,880 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $29,048,173 | 37,596 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $17,261,328 | 22,363 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $9,887,517 | 17,585 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $5,072,550 | 9,662 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $21,402,091 | 33,745 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $32,760,769 | 45,991 | Shares | Sole | 2025-03-17 | |
| 2024-09-30 | $32,582,132 | 30,994 | Shares | Sole | 2024-10-24 | |
| 2024-09-30 | $946,116 | 900 | Call | Sole | 2024-10-24 | |
| 2024-06-30 | $24,840,043 | 23,634 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $22,282,605 | 23,151 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $18,214,856 | 20,739 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $14,911,212 | 18,119 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,500,008 | 4,871 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $3,601,379 | 4,383 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $2,992,740 | 4,148 | Shares | Sole | 2023-02-01 | |
| No filing history on record for this holder in this stock. | ||||||